世界のエクソソーム診断&治療市場2023年-2027年

【英語タイトル】Global Exosome Diagnostics and Therapeutics Market 2023-2027

Technavioが出版した調査資料(IRTNTR71819-23)・商品コード:IRTNTR71819-23
・発行会社(調査会社):Technavio
・発行日:2023年3月14日
・ページ数:約120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:北米、ヨーロッパ、アジア、その他地域
・産業分野:生命科学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Technavio社の本調査レポートによると、世界のエクソソーム診断&治療市場規模が2022年から2027年の間に483.18百万ドルに達すると予測されており、予測期間中に年平均21.55%成長すると見込まれます。本レポートではエクソソーム診断&治療の世界市場について調査し、エグゼクティブサマリー、市場状況、市場規模予測、過去の市場規模、ファイブフォース分析、エンドユーザー別(研究&学術機関、製薬&バイオ企業、商業)分析、用途別(診断、治療)分析、地域別(北米、ヨーロッパ、アジア、その他地域、アメリカ、ドイツ、中国、イギリス、日本)分析、顧客状況、推進要因・課題・動向、企業状況、企業分析などの内容を掲載しています。なお、本書には、Aethlon Medical Inc., Bio Techne Corp., BioCat GmbH, BioVision Inc., Capricor Therapeutics Inc., Cell Guidance Systems Ltd., Clara Biotech Inc., Evox Therapeutics Ltd., Hologic Inc., JSR Life Sciences LLC, Lonza Group Ltd., Miltenyi Biotec B.V. and Co. KG, Nanosomix Inc., NX PharmaGen Inc., QIAGEN NV, ReNeuron Group plc, Sarepta Therapeutics Inc, Spectris Plc, System Biosciences LLC, Thermo Fisher Scientific Inc.などの企業情報が含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模予測
・過去の市場規模
・ファイブフォース分析
・世界のエクソソーム診断&治療市場規模:エンドユーザー別
- 研究&学術機関における市場規模
- 製薬&バイオ企業における市場規模
- 商業における市場規模
・世界のエクソソーム診断&治療市場規模:用途別
- 診断における市場規模
- 治療における市場規模
・顧客状況
・世界のエクソソーム診断&治療市場規模:地域別
- 北米のエクソソーム診断&治療市場規模
- ヨーロッパのエクソソーム診断&治療市場規模
- アジアのエクソソーム診断&治療市場規模
- その他地域のエクソソーム診断&治療市場規模
- アメリカのエクソソーム診断&治療市場規模
- ドイツのエクソソーム診断&治療市場規模
- 中国のエクソソーム診断&治療市場規模
- イギリスのエクソソーム診断&治療市場規模
- 日本のエクソソーム診断&治療市場規模
・推進要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益・価格・競争・プロモーションなどの主なパラメーターを分析することにより、複数の情報源からのデータを調査・統合・統括することで、エクソソーム診断&治療市場の詳細な全体像を提示します。主要産業のインフルエンサーを特定することにより、多様な市場の側面を提示します。これらのデータは包括的​​且つ信頼性が高く、一次・二次の広範な調査の結果です。Technavio社の市場調査資料は、正確なエクソソーム診断&治療市場の成長を予測するため、定性的・定量的調査により徹底的な競合状況、詳細に及ぶベンダー選定&分析を提供します。

エクソソーム診断&治療の世界市場 2023-2027

Technavio社は、エクソソーム診断&治療市場をモニターしており、2022年から2027年にかけて483.18百万米ドルの成長が予測され、予測期間中のCAGRは21.55%で加速すると予測しています。当レポートでは、エクソソーム診断&治療市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場全体の環境に関する最新分析を提供しています。エクソソーム治療薬に関する研究の増加、慢性疾患に対する効果的な薬剤に対する需要の増加、癌の早期発見に対する注目の高まりが市場を牽引しています。

Technavio社のエクソソーム診断&治療市場は以下のように分類されます:

・エンドユーザー別:
- 研究機関・学術機関
- 製薬・バイオテクノロジー企業
- 商業

・用途別:
- 診断薬
- 治療

・地域別:
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本調査では、エクソソーム収集における先端技術が、今後数年間のエクソソーム診断&治療市場の成長を促進する主要な理由の1つであると特定しています。また、戦略的パートナーシップやM&A、再生医療への注目の高まりは、市場の大きな需要につながるでしょう。

Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。当レポートでは、

エクソソーム診断&治療市場について、以下の分野をカバーしています:
- エクソソーム診断&治療市場のサイジング
- エクソソーム診断&治療市場の予測
- エクソソーム診断&治療市場の産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、Aethlon Medical Inc., Bio Techne Corp., BioCat GmbH, BioVision Inc., Capricor Therapeutics Inc., Cell Guidance Systems Ltd., Clara Biotech Inc., Evox Therapeutics Ltd., Hologic Inc., JSR Life Sciences LLC, Lonza Group Ltd., Miltenyi Biotec B.V. and Co. KG, Nanosomix Inc., NX PharmaGen Inc., QIAGEN NV, ReNeuron Group plc, Sarepta Therapeutics Inc, Spectris Plc, System Biosciences LLC, and Thermo Fisher Scientific Incなどの企業情報が含まれています。また、エクソソーム診断&治療市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。
Technavio社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global exosome diagnostics and therapeutics market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global exosome diagnostics and therapeutics market 2017 – 2021 ($ million)
o 4.2 End-user Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
o 4.3 Application Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Application Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user – Market share 2022-2027 (%)
o Exhibit 31: Data Table on End-user – Market share 2022-2027 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Research and academic institutes – Market size and forecast 2022-2027
o Exhibit 34: Chart on Research and academic institutes – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Research and academic institutes – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Research and academic institutes – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Research and academic institutes – Year-over-year growth 2022-2027 (%)
o 6.4 Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027
o Exhibit 38: Chart on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
o 6.5 Commercial – Market size and forecast 2022-2027
o Exhibit 42: Chart on Commercial – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Commercial – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Commercial – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Commercial – Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by End-user
o Exhibit 46: Market opportunity by End-user ($ million)
o Exhibit 47: Data Table on Market opportunity by End-user ($ million)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 48: Chart on Application – Market share 2022-2027 (%)
o Exhibit 49: Data Table on Application – Market share 2022-2027 (%)
o 7.2 Comparison by Application
o Exhibit 50: Chart on Comparison by Application
o Exhibit 51: Data Table on Comparison by Application
o 7.3 Diagnostic – Market size and forecast 2022-2027
o Exhibit 52: Chart on Diagnostic – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Diagnostic – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Diagnostic – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Diagnostic – Year-over-year growth 2022-2027 (%)
o 7.4 Therapeutic – Market size and forecast 2022-2027
o Exhibit 56: Chart on Therapeutic – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Therapeutic – Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Therapeutic – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Therapeutic – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Application
o Exhibit 60: Market opportunity by Application ($ million)
o Exhibit 61: Data Table on Market opportunity by Application ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share by geography 2022-2027 (%)
o Exhibit 64: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 67: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 83: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 87: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 UK – Market size and forecast 2022-2027
o Exhibit 91: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.10 China – Market size and forecast 2022-2027
o Exhibit 95: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 99: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 103: Market opportunity by geography ($ million)
o Exhibit 104: Data Tables on Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Aethlon Medical Inc.
o Exhibit 111: Aethlon Medical Inc. – Overview
o Exhibit 112: Aethlon Medical Inc. – Business segments
o Exhibit 113: Aethlon Medical Inc. – Key offerings
o Exhibit 114: Aethlon Medical Inc. – Segment focus
o 12.4 Bio Techne Corp.
o Exhibit 115: Bio Techne Corp. – Overview
o Exhibit 116: Bio Techne Corp. – Business segments
o Exhibit 117: Bio Techne Corp. – Key news
o Exhibit 118: Bio Techne Corp. – Key offerings
o Exhibit 119: Bio Techne Corp. – Segment focus
o 12.5 Capricor Therapeutics Inc.
o Exhibit 120: Capricor Therapeutics Inc. – Overview
o Exhibit 121: Capricor Therapeutics Inc. – Product / Service
o Exhibit 122: Capricor Therapeutics Inc. – Key offerings
o 12.6 Evox Therapeutics Ltd.
o Exhibit 123: Evox Therapeutics Ltd. – Overview
o Exhibit 124: Evox Therapeutics Ltd. – Product / Service
o Exhibit 125: Evox Therapeutics Ltd. – Key offerings
o 12.7 Hologic Inc.
o Exhibit 126: Hologic Inc. – Overview
o Exhibit 127: Hologic Inc. – Business segments
o Exhibit 128: Hologic Inc. – Key news
o Exhibit 129: Hologic Inc. – Key offerings
o Exhibit 130: Hologic Inc. – Segment focus
o 12.8 JSR Life Sciences LLC
o Exhibit 131: JSR Life Sciences LLC – Overview
o Exhibit 132: JSR Life Sciences LLC – Product / Service
o Exhibit 133: JSR Life Sciences LLC – Key offerings
o 12.9 Lonza Group Ltd.
o Exhibit 134: Lonza Group Ltd. – Overview
o Exhibit 135: Lonza Group Ltd. – Business segments
o Exhibit 136: Lonza Group Ltd. – Key news
o Exhibit 137: Lonza Group Ltd. – Key offerings
o Exhibit 138: Lonza Group Ltd. – Segment focus
o 12.10 Miltenyi Biotec B.V. and Co. KG
o Exhibit 139: Miltenyi Biotec B.V. and Co. KG – Overview
o Exhibit 140: Miltenyi Biotec B.V. and Co. KG – Product / Service
o Exhibit 141: Miltenyi Biotec B.V. and Co. KG – Key offerings
o 12.11 Nanosomix Inc.
o Exhibit 142: Nanosomix Inc. – Overview
o Exhibit 143: Nanosomix Inc. – Product / Service
o Exhibit 144: Nanosomix Inc. – Key offerings
o 12.12 NX PharmaGen Inc.
o Exhibit 145: NX PharmaGen Inc. – Overview
o Exhibit 146: NX PharmaGen Inc. – Product / Service
o Exhibit 147: NX PharmaGen Inc. – Key offerings
o 12.13 QIAGEN NV
o Exhibit 148: QIAGEN NV – Overview
o Exhibit 149: QIAGEN NV – Product / Service
o Exhibit 150: QIAGEN NV – Key news
o Exhibit 151: QIAGEN NV – Key offerings
o 12.14 Sarepta Therapeutics Inc
o Exhibit 152: Sarepta Therapeutics Inc – Overview
o Exhibit 153: Sarepta Therapeutics Inc – Product / Service
o Exhibit 154: Sarepta Therapeutics Inc – Key offerings
o 12.15 Spectris Plc
o Exhibit 155: Spectris Plc – Overview
o Exhibit 156: Spectris Plc – Business segments
o Exhibit 157: Spectris Plc – Key news
o Exhibit 158: Spectris Plc – Key offerings
o Exhibit 159: Spectris Plc – Segment focus
o 12.16 System Biosciences LLC
o Exhibit 160: System Biosciences LLC – Overview
o Exhibit 161: System Biosciences LLC – Product / Service
o Exhibit 162: System Biosciences LLC – Key offerings
o 12.17 Thermo Fisher Scientific Inc.
o Exhibit 163: Thermo Fisher Scientific Inc. – Overview
o Exhibit 164: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 165: Thermo Fisher Scientific Inc. – Key news
o Exhibit 166: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 167: Thermo Fisher Scientific Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 168: Inclusions checklist
o Exhibit 169: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 170: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 171: Research methodology
o Exhibit 172: Validation techniques employed for market sizing
o Exhibit 173: Information sources
o 13.5 List of abbreviations
o Exhibit 174: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by End-user
Exhibits6: Executive Summary – Chart on Market Segmentation by Application
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global exosome diagnostics and therapeutics market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Application Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on End-user – Market share 2022-2027 (%)
Exhibits31: Data Table on End-user – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Research and academic institutes – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Research and academic institutes – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Research and academic institutes – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Research and academic institutes – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Commercial – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Commercial – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Commercial – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Commercial – Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by End-user ($ million)
Exhibits47: Data Table on Market opportunity by End-user ($ million)
Exhibits48: Chart on Application – Market share 2022-2027 (%)
Exhibits49: Data Table on Application – Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Application
Exhibits51: Data Table on Comparison by Application
Exhibits52: Chart on Diagnostic – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Diagnostic – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Diagnostic – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Diagnostic – Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Therapeutic – Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Therapeutic – Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Therapeutic – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Therapeutic – Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Application ($ million)
Exhibits61: Data Table on Market opportunity by Application ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share by geography 2022-2027 (%)
Exhibits64: Data Table on Market share by geography 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity by geography ($ million)
Exhibits104: Data Tables on Market opportunity by geography ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Aethlon Medical Inc. – Overview
Exhibits112: Aethlon Medical Inc. – Business segments
Exhibits113: Aethlon Medical Inc. – Key offerings
Exhibits114: Aethlon Medical Inc. – Segment focus
Exhibits115: Bio Techne Corp. – Overview
Exhibits116: Bio Techne Corp. – Business segments
Exhibits117: Bio Techne Corp. – Key news
Exhibits118: Bio Techne Corp. – Key offerings
Exhibits119: Bio Techne Corp. – Segment focus
Exhibits120: Capricor Therapeutics Inc. – Overview
Exhibits121: Capricor Therapeutics Inc. – Product / Service
Exhibits122: Capricor Therapeutics Inc. – Key offerings
Exhibits123: Evox Therapeutics Ltd. – Overview
Exhibits124: Evox Therapeutics Ltd. – Product / Service
Exhibits125: Evox Therapeutics Ltd. – Key offerings
Exhibits126: Hologic Inc. – Overview
Exhibits127: Hologic Inc. – Business segments
Exhibits128: Hologic Inc. – Key news
Exhibits129: Hologic Inc. – Key offerings
Exhibits130: Hologic Inc. – Segment focus
Exhibits131: JSR Life Sciences LLC – Overview
Exhibits132: JSR Life Sciences LLC – Product / Service
Exhibits133: JSR Life Sciences LLC – Key offerings
Exhibits134: Lonza Group Ltd. – Overview
Exhibits135: Lonza Group Ltd. – Business segments
Exhibits136: Lonza Group Ltd. – Key news
Exhibits137: Lonza Group Ltd. – Key offerings
Exhibits138: Lonza Group Ltd. – Segment focus
Exhibits139: Miltenyi Biotec B.V. and Co. KG – Overview
Exhibits140: Miltenyi Biotec B.V. and Co. KG – Product / Service
Exhibits141: Miltenyi Biotec B.V. and Co. KG – Key offerings
Exhibits142: Nanosomix Inc. – Overview
Exhibits143: Nanosomix Inc. – Product / Service
Exhibits144: Nanosomix Inc. – Key offerings
Exhibits145: NX PharmaGen Inc. – Overview
Exhibits146: NX PharmaGen Inc. – Product / Service
Exhibits147: NX PharmaGen Inc. – Key offerings
Exhibits148: QIAGEN NV – Overview
Exhibits149: QIAGEN NV – Product / Service
Exhibits150: QIAGEN NV – Key news
Exhibits151: QIAGEN NV – Key offerings
Exhibits152: Sarepta Therapeutics Inc – Overview
Exhibits153: Sarepta Therapeutics Inc – Product / Service
Exhibits154: Sarepta Therapeutics Inc – Key offerings
Exhibits155: Spectris Plc – Overview
Exhibits156: Spectris Plc – Business segments
Exhibits157: Spectris Plc – Key news
Exhibits158: Spectris Plc – Key offerings
Exhibits159: Spectris Plc – Segment focus
Exhibits160: System Biosciences LLC – Overview
Exhibits161: System Biosciences LLC – Product / Service
Exhibits162: System Biosciences LLC – Key offerings
Exhibits163: Thermo Fisher Scientific Inc. – Overview
Exhibits164: Thermo Fisher Scientific Inc. – Business segments
Exhibits165: Thermo Fisher Scientific Inc. – Key news
Exhibits166: Thermo Fisher Scientific Inc. – Key offerings
Exhibits167: Thermo Fisher Scientific Inc. – Segment focus
Exhibits168: Inclusions checklist
Exhibits169: Exclusions checklist
Exhibits170: Currency conversion rates for US$
Exhibits171: Research methodology
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Information sources
Exhibits174: List of abbreviations



★調査レポート[世界のエクソソーム診断&治療市場2023年-2027年] (コード:IRTNTR71819-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のエクソソーム診断&治療市場2023年-2027年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆